![PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease](https://i1.rgstatic.net/publication/330967957_Identification_of_Chitinase-3-Like_Protein_1_as_a_Novel_Neutrophil_Antigenic_Target_in_Crohn's_Disease/links/5c5d8f4a299bf1d14cb497c9/largepreview.png)
PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease
![PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review](https://i1.rgstatic.net/publication/335169689_Outcomes_and_Strategies_to_Support_a_Treat-to-target_Approach_in_Inflammatory_Bowel_Disease_A_Systematic_Review/links/5e6fcca9299bf14570f25fea/largepreview.png)
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
![Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission | Frontline Gastroenterology Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission | Frontline Gastroenterology](https://fg.bmj.com/content/flgastro/early/2020/01/24/flgastro-2019-101366/F1.large.jpg)
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission | Frontline Gastroenterology
![Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1555415519301916-gr1.jpg)
Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect
![A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study | Pharmacogenomics A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.11.32/asset/images/medium/figure1.gif)
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study | Pharmacogenomics
![PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review](https://www.researchgate.net/publication/335169689/figure/fig2/AS:869788771446786@1584385211703/Schematic-illustration-of-factors-that-may-play-a-role-in-a-treat-totarget-strategy-in_Q320.jpg)
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
![Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1555415519301916-gr2.jpg)